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Abstract Over the last years, significant progress has been
made in the understanding of the genetics and enzymology of the
biosynthetic pathway of the vitamin biotin. The enzymes
catalyzing the last four steps of this pathway, from pimeloyl-
CoA to biotin, provide an ensemble of intriguing reaction
mechanisms, which are presently being unravelled. The three-
dimensional structures for three of these enzymes are known and
provide a framework to which on-going mechanistic studies can
be related. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Biotin (vitamin H) is a cofactor in a number of enzymatic
carboxylation reactions, and is present only in very small
amounts in mammalian cells. The biosynthesis pathways of
this essential cofactor have been studied in detail in Escheri-
chia coli [1,2], Bacillus sphaericus [3], Bacillus subtilis [4], Sac-
charomyces cerevisiae [5] and higher plants [6]. Because biotin
biosynthesis is unique to plants and many microorganisms,
enzymes of this pathway are potential targets for the develop-
ment of safe antimicrobial drugs and herbicides [7].
The biotin biosynthesis genes in E. coli are located in a
cluster, which consists of ¢ve genes, bioABFCD [2]. With
the exception of bioC, which might be involved in an early
step of biotin biosynthesis, these genes code for enzymes cat-
alyzing the four last steps in the pathway (Fig. 1). In E. coli,
the bio operon is negatively regulated by the action of BirA,
the repressor of biotin biosynthesis [8] which binds to the
translational control region of the bio operon [9]. In B. subtilis
a single bio operon was found, bioWAFDBI [4], whereas in
B. sphaericus two gene clusters, bioXWF and bioDAYB, were
described [3]. In addition to these studies, whole genome se-
quencing e¡orts have provided information on biotin biosyn-
thetic genes from a number of other microorganisms. From
these studies it appears that the last four steps of biotin bio-
synthesis, from pimeloyl-CoA to biotin, are common to most
bacteria and plants (Fig. 1). The di¡erent chemical events
necessary for the formation of biotin from the precursor pi-
meloyl-CoA provide an ensemble of intriguing enzymatic re-
action mechanisms, which have attracted considerable atten-
tion during the last decade.
2. 7-Keto-8-amino pelargonic acid synthase
7-Keto-8-amino pelargonic acid (KAPA) synthase (also
known as 8-amino-7-oxononanoate synthase, EC 2.3.1.47) is
a homodimeric, pyridoxal phosphate-dependent enzyme that
catalyzes the ¢rst committed step of the pathway (Fig. 1). The
enzyme subunit has a molecular mass of about 42 kDa. Ami-
no acid sequence comparisons and the 3D structure of the
enzyme [10] suggested that KAPA synthase belongs to the
fold type I family of vitamin B6-dependent enzymes and is a
member of the aminotransferase subclass II [11]. Within this
subclass, KAPA synthase forms a small subfamily of K-oxo-
amine synthases, with 5-aminolevulinate synthase, serine pal-
mitoyltransferase, and 2-amino-3-oxobutyrate CoA ligase as
the other members [10,12]. Indeed, studies using recombinant
KAPA synthase from B. sphaericus demonstrate that the re-
action mechanism employed by KAPA synthase is very sim-
ilar to that of 5-aminolevulinate synthase, thus providing evi-
dence that the similarities extend beyond structure and also
include the chemistry [12]. This work led to the design of
KAPA synthase inhibitors, with the most potent inhibitor
8-amino-7-oxo-8-phosphononanoic acid (Ki 7 WM) derived
from the structure of a putative reaction intermediate [13].
The crystal structure of KAPA synthase (Fig. 1) from E. coli
was determined in the apo- and holoform [10] and as the
enzyme^product external aldimine complex [14]. The subunit
of KAPA synthase folds into two domains, a large domain
containing a seven-stranded L-sheet, and a smaller domain,
comprising the C-terminal part of the polypeptide chain.
The C-terminal consists of a four-stranded L-sheet with helices
on one side. The N-terminal part of the polypeptide chain
forms a small three-stranded L-sheet, which extends the sheet
of the C-terminal domain. Pyridoxal phosphate is bound in a
crevice between the two subunits in the dimer and residues
from both subunits are involved in cofactor binding. In the
holoenzyme, the cofactor is covalently linked to the O-amino
group of a lysine residue, a residue conserved in the whole
enzyme family. The X-ray analysis of the holoenzyme and the
enzyme^product external aldimine complex provided the
structural framework for a mechanistic proposal for catalysis
by KAPA synthase which may be of general importance for
other members of the K-oxoamine family [14]. Essential steps
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of this mechanism [12,14] are formation of an external aldi-
mine between pyridoxal 5P-phosphate (PLP) and the sub-
strate, L-alanine. Abstraction of the C2-H proton of the aldi-
mine, possibly by Lys236 (E. coli numbering), leads to a
quinonoid intermediate, which then attacks the thioester car-
bonyl of pimeloyl-CoA. Release of HSCoA produces a L-ke-
toacid aldimine, which after decarboxylation is converted into
the product.
3. 7,8-Diaminopelargonic acid synthase
The antepenultimate step in this pathway, the conversion of
KAPA to 7,8-diaminopelargonic acid (DAPA), is catalyzed by
DAPA synthase, another vitamin B6-dependent enzyme (Fig.
1) [15]. DAPA synthase from E. coli is a homodimer with a
molecular mass of 94 kDa [15,16] and contains 429 residues
per monomer [2]. The enzyme uses S-adenosyl-L-methionine
Fig. 1. The pathway of biotin biosynthesis, common for most microorganisms and plants. Schematic views of the 3D structure of the enzymes
are included if known.
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as amino group donor, an unusual feature among aminotrans-
ferases [15]. Sequence comparisons suggested that DAPA syn-
thase belongs to a subclass of the fold type I family of PLP-
dependent enzymes [17] and the crystal structure analysis [18]
identi¢ed DAPA synthase as a member of the aminotransfer-
ase subclass II of this fold family [11].
The overall structure of DAPA synthase is very similar to
the structure of KAPA synthase. Together with the amino
acid sequence homology, albeit weak, this suggests that the
two enzymes might be evolutionarily related, and possibly
derived from a common ancestor [2]. From the structure of
the non-productive complex of the holoenzyme with the sub-
strate KAPA, the location of the active site and residues in-
volved in substrate binding were identi¢ed.
An intriguing observation is the absence of transamination
in DAPA synthase catalysis [19]. Since KAPA is an amino
acid, it could in principle act as an amino group donor, and
not only as an amino group acceptor in the reaction. The
structure of the enzyme^PLP^KAPA complex [18] provided
the structural explanation for how the enzyme avoids this
unwanted side reaction.
4. Dethiobiotin synthetase
This enzyme catalyzes the ATP-dependent formation of de-
thiobiotin from DAPA and CO2. Dethiobiotin synthetase
(DTBS) is a homodimer, with a subunit molecular mass of
24 kDa. The crystal structure of the apo-enzyme [20^22] re-
vealed that the polypeptide chain folds into a single domain,
containing a seven-stranded parallel L-sheet, with helices on
both sides. This fold was also observed in other phospho-
transferases, such as adenylate kinase and p21ras. In the ho-
modimer, the two equivalent active sites, about 25 Aî apart,
are located at the interface between the subunits. Crystallo-
graphic studies of complexes of DTBS with nucleotides, sub-
strates and substrate analogs [23^26] provide detailed insights
into the active site and conformational changes upon binding
of substrate, and revealed conserved amino acids involved in
binding of substrates and catalysis.
The catalytic steps during the turnover of DAPA and CO2
to dethiobiotin were already proposed by Eisenberg and co-
workers [27] (Fig. 2). The ¢rst step of the reaction is the
formation of a DAPA carbamate. The regiospeci¢city of
DAPA carbamylation was addressed by two independent
crystallographic studies which both showed speci¢c carbamate
formation at N7 of the DAPA molecule [23,24]. These studies
also suggest that carbamylation of DAPA is part of the en-
zyme-catalyzed reaction cycle. Independent evidence for car-
bamate formation at this position was provided by the use of
1H and 13C NMR pulse-chase experiments, and synthesis and
inhibition patterns of carbamate analogs [28].
A second reaction intermediate is formed by transfer of the
Q-phosphoryl group from ATP to a carbamate oxygen [29,30].
Compelling evidence for the existence of this intermediate, a
mixed carbamic^phosphoric acid anhydride, in the catalytic
cycle of DTBS comes from time-resolved crystallographic
studies [25]. The phosphoryl transfer step shows inversion of
the con¢guration at the phosphorus atom, consistent with an
in-line attack by the carbamate oxygen onto the phosphorus
atom of ATP. A key feature in the structure of the enzyme^
intermediate complex determined at 1.6 Aî resolution is two
magnesium ions, bridging the phosphates at the cleavage site.
These magnesium ions compensate the negative charges at
both phosphate groups after phosphoryl transfer and contrib-
ute to the stabilization of the reaction intermediate [25]. An-
other important interaction of the phosphate oxygens of ATP
is a salt bridge to the invariant residue Lys15. The analysis of
site-directed mutants at this position of DTBS is consistent
with key roles of Lys15 in Q-phosphoryl transfer to the carba-
mate and stabilization of the phosphorylated intermediates,
and binding of ATP [31].
The ¢nal step of DTBS catalysis involves nucleophilic at-
tack of the N8 nitrogen onto the carbonyl oxygen of the
carbamate, with subsequent release of the phosphate group
and formation of the ureido ring of dethiobiotin (Fig. 2). It
was postulated that a third reaction intermediate is formed in
this step [23,31]. However, this intermediate has so far been
elusive and there is as yet little evidence for its existence in the
catalytic cycle. Observed di¡erences in the binding of sub-
strate, DAPA and the product dethiobiotin at the active site
of the enzyme suggest considerable displacements of substrate
atoms during the ring closure step of the catalytic reaction,
best described as rotation of the ureido ring of dethiobiotin by
almost 180‡ [26].
Only minor conformational changes of the enzyme are ob-
served in the various enzyme complexes. A signi¢cant excep-
tion involves the phosphate binding loop (Gly8-X-X-X-X-X-
Gly14-Lys15-Thr16) which changes conformation upon bind-
ing of ADP, ATP and ATP analogs [23]. This displacement
brings main chain atoms of residues 12, 13 and 14 close to
the phosphate groups of the nucleotide resulting in the for-
mation of hydrogen bonds. Replacement of one of the resi-
dues in this loop, Thr11Val, results in a 24 000-fold increase
in the KM for ATP, with little change in kcat, thus emphasizing
the importance of this loop in the binding of the cosubstrate,
ATP [31].
5. Biotin synthase
The ¢nal step of biotin biosynthesis is chemically the most
challenging: the insertion of a sulfur atom between the non-
Fig. 2. Reaction mechanism for DTBS. The intermediate which has
not yet been veri¢ed by crystallographic studies is shown in red.
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reactive methyl and methylene carbon atoms adjacent to the
ureido ring of dethiobiotin (Fig. 1). In enzymological terms,
this reaction of the pathway is also least understood. Compel-
ling evidence was assembled that the product of the bioB gene,
in the literature referred to as biotin synthase, is essential for
this reaction to occur [32^36]. However, there is at present no
in vitro assay where biotin synthase sustains biotin formation
at catalytic rates.
The bioB gene of E. coli codes for a polypeptide of about 38
kDa [2,32] and the active species of the protein appears to be
the homodimer. When isolated aerobically in the oxidized
form, the monomer contains a [2Fe^2S] cluster [32,37,38],
upon reduction, however, a [4Fe^4S] cluster is formed [37^
39]. Incubation with excess iron and sul¢de results in a protein
containing two [4Fe^4S] clusters per dimer, which might be
the redox-active species in the anaerobic enzyme [38,39].
Biotin synthase contains a sequence motif encompassing
three cysteine residues, the cysteine box, which is also found
in other S-adenosylmethionine-dependent enzymes containing
Fe^S clusters such as anaerobic ribonucleotide reductase and
pyruvate formate lyase activating enzyme. The results of mu-
tagenesis studies focusing on these three conserved cysteine
residues (Cys53, Cys57, and Cys60) in E. coli biotin synthase
[40,41] are consistent with these residues contributing ligands
to the irons of the cluster.
The conversion of dethiobiotin to biotin by biotin synthase
requires the presence of a reducing system, usually NADPH,
£avodoxin (or ferredoxin) and £avodoxin (or ferredoxin)
NADP+reductase, and S-adenosylmethionine. The latter
does not act as the sulfur donor in the reaction, but is cleaved
to methionine and a 5P-deoxyadenosyl radical [36], possibly
facilitated by the Fe^S clusters [37]. This radical can then
react further with the substrate, by abstraction of a hydrogen
atom at the methyl and a methylene group of the substrate.
This requires two equivalents of S-adenosylmethionine per
molecule of biotin formed, consistent with the observed stoi-
chiometry [35,36].
The origin of the sulfur incorporated in biotin has been the
focus of a number of studies. Recent work provides evidence
that the sulfur is donated by biotin synthase itself [42,43], in
fact by the Fe^S cluster [42]. It appears that biotin synthase
acts as a substrate rather than an enzyme in this reaction,
which explains the failure to sustain multiple turnovers. In
order to restore activity the Fe^S centers have to be regener-
ated. In a recent study [44], it was shown that the NifS protein
from Azotobacter vinelandii, the C-DES protein from Syne-
chocystis as well as rhodanese from bovine liver all can cata-
lyze incorporation of sulfur derived from cysteine into apo-
biotin synthase, resulting in active reconstituted biotin syn-
thase. Importantly, however, these proteins had no e¡ect on
the turnover of biotin synthase in the in vitro assay. The
question then arises whether the present failure to experimen-
tally demonstrate multiple turnover is due to missing compo-
nents in the assay mixture or indeed, if the last step of biotin
synthesis is enzyme-catalyzed at all. The latter implies that
each ‘biotin synthase’ molecule functions only once, making
biotin biosynthesis a very costly enterprise [43].
There are thus a number of intriguing mechanistic questions
concerning the enzymology of this last step in biotin biosyn-
thesis, which are as yet unresolved. A major obstacle is the
absence of structural information on biotin synthase and it
can be expected that the determination of the 3D structure
will advance our understanding of the function of this elusive
enzyme.
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